Navigation Links
Experimental radioprotective drug safe for lung cancer patients, says Pitt study
Date:3/22/2011

PITTSBURGH, March 22 Patients with advanced non-small cell lung cancer can safely take an experimental oral drug intended to protect healthy tissue from the effects of radiation, according to a study led by researchers at the University of Pittsburgh Cancer Institute (UPCI) and published in this month's issue of Human Gene Therapy.

The findings support further clinical testing of the agent, called manganese superoxide dismutase (MnSOD) plasmid liposome, to determine if giving it alongside chemotherapy and radiation will prevent damage to normal cells that is the typical cause of side effects in cancer treatment, said senior investigator Joel S. Greenberger, M.D., professor and chair, Department of Radiation Oncology, Pitt School of Medicine, and co-director of the lung and esophageal cancer program at UPCI.

"If we can sufficiently protect tissues that are normal, we should be able to deliver our cancer treatments more effectively and perhaps even at higher doses," he explained. "Our aim is to improve the quality of life of patients by minimizing side effects while providing the best treatment for their cancers."

For the safety study, 10 patients with inoperable stage III non-small cell lung cancer took oral doses of MnSOD plasmid liposome twice weekly for a total of 14 doses during seven weeks of conventional chemotherapy and radiation treatment. The agent, which boosts levels of an antioxidant the body makes naturally, is made of fat droplets containing the gene that produces MnSOD. When swallowed, it is absorbed by cells in the esophagus, which is a common site for severe side effects during radiation treatment for lung cancer.

One patient experienced mild heartburn and a slight rash and another had mild constipation and a fluctuation in blood sodium, problems that might be associated with MnSOD treatment. No other toxicities were thought to be due to the experimental drug.

"The results of this initial tr
'/>"/>

Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-578-9193
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. A stem cell secreted protein can be given to improve heart function after experimental heart attack
2. Flemish researchers provide the first experimental evidence of dynamic allostery in protein regulation
3. Experimental treatment protects monkeys from lethal Ebola virus post-exposure
4. Selected highlights of the research being presented at the Experimental Biology 2010 meeting
5. Experimental vaccine protects monkeys against chikungunya
6. Experimental drug shows promise against brain, prostate cancers
7. French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009
8. Experimental treatments restore partial vision to blind people
9. Experimental treatment halts hypoxic-ischemic brain injury in newborns
10. 40 minority scientists receive travel fellowships to Experimental Biology 2009 in New Orleans
11. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/12/2015)... , March 12, 2015 IriTech, a ... a member of the Texas Instruments Design Network, announced ... has demonstrated its IriShield USB MK2120U device during ... facility for pension distribution. The iris ... to be marketed in India ...
(Date:3/12/2015)... March 12, 2015 WHEN:Tuesday, March 17, 2015 ... http://bit.ly/1G7Os0L . SPEAKERS: , Frost & Sullivan ... http://photos.prnewswire.com/prnh/20150311/181111 Biometric companies must ... in several different markets and industries. This is ... an uptrend. Join Frost & ...
(Date:3/10/2015)... NEW YORK , March 10, 2015  Continuing ... and the Unexpected, Hammacher Schlemmer introduces The Eye ... user,s identity before granting access to secure websites or ... trusted to verify travelers at international borders, the device ... 240 distinctive pattern points of the iris, converting them ...
Breaking Biology News(10 mins):Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... working to create "protocells" primitive synthetic cells consisting ... compartment have accomplished an important step towards their ... Science , the investigators describe a solution to ... potential incompatibility between a chemical requirement of RNA copying ...
... a team of UC San Diego biophysicists has discovered ... to multiply in the presence of antibiotics, a growing ... United States. , Two months ago, the Centers for ... that antibiotic-resistant bacteria last year caused more than two ...
... have developed a series of techniques to create a ... the alcohols and amines used in the drug and ... safer and more economical and environmentally friendly than traditional ... extensive supply of iron the fifth most abundant ...
Cached Biology News:Researchers find a missing component in effort to create primitive, synthetic cells 2Researchers find a missing component in effort to create primitive, synthetic cells 3Quantitative approaches provide new perspective on development of antibiotic resistance 2Quantitative approaches provide new perspective on development of antibiotic resistance 3Iron-based process promises greener, cheaper and safer drug and perfume production 2
(Date:3/31/2015)... Florida (PRWEB) March 31, 2015 Today, ... the official relocation of their U.S. facilities and inventory ... than 25 years of experience, Cryos’ relocation is a ... , The move to Orlando was completed during the ... an official opening taking place on April 6. The ...
(Date:3/30/2015)... -- Multiple new research abstracts suggest walnuts may have the ... their impact on colon cancer and certain aspects of ... health and vascular health, the research findings presented at ... walnuts, inner workings. Running March 28 through April 1 ... attracts an international audience of over 14,000 leading research ...
(Date:3/30/2015)... March 30, 2015 CASI Pharmaceuticals, Inc. (Nasdaq: ... acquisition, development and commercialization of innovative therapeutics addressing cancer ... with a commercial focus on China ... Administration (CFDA) has approved the Company,s application to conduct ... cell carcinoma (OCCC) patients for its proprietary drug candidate ...
(Date:3/30/2015)... OXFORD, England , March 30, 2015 /PRNewswire/ ... company developing novel biological drugs to treat cancer, ... appointment of Professor Sir John Bell , ... and Chairman of the Office for the Strategic ... Directors with immediate effect.      (Photo: ...
Breaking Biology Technology:Cryos International Completes Groundbreaking Sperm Migration to Orlando, Florida 2New Findings Support the Benefits of Eating Walnuts on Overall Health 2New Findings Support the Benefits of Eating Walnuts on Overall Health 3New Findings Support the Benefits of Eating Walnuts on Overall Health 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5
... MILWAUKEE--- GE Healthcare , a $10 billion provider ... information technology, announced today that it has received ... healthcare industry authority, KLAS Enterprises for the second ... called Centricity(R) Pharmacy Information System, was recognized in ...
... OASYS , a leading developer of K-12 software ... Behind management, recently announced their online, ASP software ... (IEPs) and monitors the progress of children with ... in 16 Wisconsin school districts during 2003, provides ...
... Third Wave Technologies Inc , a maker of molecular ... 2D6 analysis panel, which provides clinical trial laboratories with ... for the important 2D6 gene. , ,The panel is ... the ability to configure custom assay panels. The panel ...
Cached Biology Technology:Third Wave Releases Gene Test 2
Reacti-Bind DNA Coating Solution...
... Our Smart Solutions has now entered the ... (HCS) by partnering up with Cellomics, Inc. ... the integration of Beckman Coulter‘s automated solutions ... deeper biological information at the sub-cellular level. ...
... assay reagents package is used for determining protein ... detergents. The RC DC protein assay is a ... 500 standard assays: 250 ml RC reagent I, ... copper tartrate solution, 2 L dilute Folin reagent, ...
... Glycosylation is a post-translational modification that ... functions, including immune regulation, inflammation, cell-to-cell ... has developed two lectin based Glycoprotein ... Wheat Germ Agglutinin (WGA), that allow ...
Biology Products: